The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
出版年份 2014 全文链接
标题
The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
作者
关键词
-
出版物
Frontiers in Oncology
Volume 4, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2014-05-20
DOI
10.3389/fonc.2014.00111
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
- (2015) Wilko Weichert et al. NEOPLASIA
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer
- (2014) Panagiotis A. Konstantinopoulos et al. GYNECOLOGIC ONCOLOGY
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function
- (2013) M. R. Heideman et al. BLOOD
- A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
- (2013) F. Santoro et al. BLOOD
- Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity
- (2013) Brendon Ladd et al. DNA REPAIR
- Increased Incidence of Severe Gastrointestinal Events With First-Line Paclitaxel, Carboplatin, and Vorinostat Chemotherapy for Advanced-Stage Epithelial Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- (2013) Alberto A. Mendivil et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- HDAC3 is essential for DNA replication in hematopoietic progenitor cells
- (2013) Alyssa R. Summers et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
- (2013) Noriyuki Katsumata et al. LANCET ONCOLOGY
- Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
- (2013) Christina E. Wells et al. PLoS One
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses
- (2013) J E Bolden et al. Cell Death & Disease
- Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
- (2013) Yanfang Li et al. Frontiers in Oncology
- Targeting class I histone deacetylases in cancer therapy
- (2012) Geneviève P Delcuve et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer
- (2012) Andrew J. Wilson et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: A gynecologic oncology group study
- (2012) Don S. Dizon et al. GYNECOLOGIC ONCOLOGY
- Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer
- (2012) Don S. Dizon et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB
- (2012) Elisabeth Ziesché et al. NUCLEIC ACIDS RESEARCH
- Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages
- (2012) X. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nuclear factor- B binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome
- (2012) Q. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
- (2012) Andrew J Wilson et al. Journal of Ovarian Research
- Distinct Subpopulations of Epithelial Ovarian Cancer Cells Can Differentially Induce Macrophages and T Regulatory Cells Toward a Pro-Tumor Phenotype
- (2011) Ayesha B. Alvero et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells
- (2011) Andrew J. Wilson et al. CANCER BIOLOGY & THERAPY
- A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
- (2011) H. Kulbe et al. CANCER RESEARCH
- Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination
- (2011) Miglena Koprinarova et al. DNA REPAIR
- Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation
- (2011) S. E. Mullican et al. GENES & DEVELOPMENT
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
- (2011) J. Krempski et al. JOURNAL OF IMMUNOLOGY
- Thailandepsins: Bacterial Products with Potent Histone Deacetylase Inhibitory Activities and Broad-Spectrum Antiproliferative Activities
- (2011) Cheng Wang et al. JOURNAL OF NATURAL PRODUCTS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Sensitization to γ-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells
- (2010) Feng Zhang et al. CANCER BIOLOGY & THERAPY
- The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21
- (2010) Deok-Soo Son et al. CANCER BIOLOGY & THERAPY
- Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability
- (2010) Srividya Bhaskara et al. CANCER CELL
- Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
- (2010) Chiara Conti et al. CANCER RESEARCH
- A work in progress: The clinical development of histone deacetylase inhibitor
- (2010) Silvia Marsoni et al. Epigenetics
- HDACs and HDAC inhibitors in colon cancer
- (2010) John M. Mariadason Epigenetics
- Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours
- (2010) Helen J. Mackay et al. EUROPEAN JOURNAL OF CANCER
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- Histone deacetylase inhibitors as anti-neoplastic agents
- (2009) Nicolas Batty et al. CANCER LETTERS
- Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
- (2009) Ailsa J. Frew et al. CANCER LETTERS
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- HDAC2 regulates chromatin plasticity and enhances DNA vulnerability
- (2009) D. C. Marchion et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: Potential role of histone deacetylase 6
- (2009) In Ah Kim et al. RADIOTHERAPY AND ONCOLOGY
- Histone deacetylase inhibitors and genomic instability
- (2008) Grégory Eot-Houllier et al. CANCER LETTERS
- Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs
- (2008) Kei-ichi Ozaki et al. CANCER SCIENCE
- Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
- (2008) Sarah K Knutson et al. EMBO JOURNAL
- A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2008) Susan C. Modesitt et al. GYNECOLOGIC ONCOLOGY
- Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer
- (2008) Franco Muggia GYNECOLOGIC ONCOLOGY
- Acetylation of non-histone proteins modulates cellular signalling at multiple levels
- (2008) Stephanie Spange et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- “Re-educating” tumor-associated macrophages by targeting NF-κB
- (2008) Thorsten Hagemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
- (2008) Andrew J. Wilson et al. MOLECULAR BIOLOGY OF THE CELL
- Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control
- (2008) Srividya Bhaskara et al. MOLECULAR CELL
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now